title: Persistence with statins and incident cataract: a population-based historical cohort study.
abstract: OBJECTIVE
  In recent years, there is a growing body of evidence suggesting that statins may have anti-inflammatory effects; consequently, it was hypothesized that statins may have a preventive effect against cataract.
  
  
  METHODS
  The study was carried out on a retrospective cohort of 180,291 new statin users in a large health organization in Israel. Study participants were followed between 1998 and 2007 for incident cataract or cataract extraction.
  
  
  RESULTS
  During the study period 27,301 cataracts were diagnosed and 6,976 cataract extractions were performed among study participants. Persistence with statins was associated significantly (P < 0.001) with a reduced risk of cataract in men and women aged 45 to 74. Men aged 45-54 with a high (>80%) proportion of follow-up days covered with statins had an adjusted hazard ratio of 0.62 (95% confidence interval: 0.54-0.72), compared with patients with low persistence with statins. In elderly patients, no relationship or a positive relationship was observed.
  
  
  CONCLUSIONS
  Persistent statin use was significantly protective for the incidence of cataract in men and women under 75 years of age.
authors.affiliation: Tel Aviv University, Israel. hodik_g@mac.org.il
authors.forename: Gabriel
authors.initials: G
authors.lastname: Chodick
authors.forename: Anthony D
authors.initials: AD
authors.lastname: Heymann
authors.forename: Shira
authors.initials: S
authors.lastname: Flash
authors.forename: Ehud
authors.initials: E
authors.lastname: Kokia
authors.forename: Varda
authors.initials: V
authors.lastname: Shalev
mesh_terms: D000328:Adult; D000368:Aged; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage*; D002386:Cataract / Q000453:epidemiology* / Q000517:prevention & control / Q000628:therapy; D002387:Cataract Extraction; D015331:Cohort Studies; D005260:Female; D006279:Health Maintenance Organizations; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000008:administration & dosage*; D007557:Israel / Q000453:epidemiology; D008297:Male; D008499:Medical Records; D008875:Middle Aged; D012189:Retrospective Studies
chemical_list: D000893:Anti-Inflammatory Agents; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors